Monday, June 28, 2021

SUNPHARMA | Stock Price Analysis

 investment ,

Sun Pharmaceutical Industries Limited

CMP  676

➽  Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. 

➽ Key Stat

Key Profit & Loss Data

Net Inc2903.8222.87 %
Ops Income6387.7733.95 %
Revenue33498.142.01 %
Ops Expense27110.372.84 %
PBT2799.3744.12 %
Gross Profit24808.0610.92 %
Div Paid-1559.4713.07 %

Next Potential Multibagger | Stock Price Analysis & Outlook 

Financial Data Highlights

Market Cap161.29 K
Book Value/ Share192.263
Enterprise Value38975.22
Revenue TTM33498.14
Gross Profit TTM24808.06
Revenue /Share TTM139.58

  Price Levels

Make long position for the levels of 714  - 738 in 1 - 3 months.

Thanks for your Precious Time.

Finvest Online
Telegram  :

Disclaimer- The information on this blog are based on my personal opinion and experience, it should not be considered professional financial investment advice and in no way it should be considered as a tip. We does not take any compensation of any kind whatsoever from any reader,user and company that are mention on this website.  Please remember that this is a blog, and you do not need to agree with anything I write.We are not SEBI registered financial advisor or analyst.

No comments:

Post a Comment